L-type calcium channel abundance and function with cardiac hypertrophy and failure: a review

scientific article

L-type calcium channel abundance and function with cardiac hypertrophy and failure: a review is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1006/JMCC.1998.0755
P698PubMed publication ID9799645

P2093author name stringMukherjee R
Spinale FG
P433issue10
P304page(s)1899-1916
P577publication date1998-10-01
P1433published inJournal of Molecular and Cellular CardiologyQ2061932
P1476titleL-type calcium channel abundance and function with cardiac hypertrophy and failure: a review
P478volume30

Reverse relations

cites work (P2860)
Q24800443Adaptations to iron deficiency: cardiac functional responsiveness to norepinephrine, arterial remodeling, and the effect of beta-blockade on cardiac hypertrophy
Q37234352Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability.
Q40807143Altered distribution of ICa impairs Ca release at the t-tubules of ventricular myocytes from failing hearts.
Q36837270Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy
Q58121711Arrhythmogenic Mechanisms in Heart Failure: Linking β-Adrenergic Stimulation, Stretch, and Calcium
Q33839788Autoregulation of cardiac l-type calcium channels
Q42425047Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling
Q26781612Cardiac cAMP: production, hydrolysis, modulation and detection
Q42490724Cardiac excitation-contraction coupling in the portal hypertensive rat.
Q52688736Caveolin 3-dependent loss of t-tubular ICa during hypertrophy and heart failure in mice.
Q54623354Decrease in the density of t-tubular L-type Ca2+ channel currents in failing ventricular myocytes.
Q40053441Decreased cardiac L-type Ca²⁺ channel activity induces hypertrophy and heart failure in mice
Q36225124Effects of Na+-Ca2+ exchange expression on excitation-contraction coupling in genetically modified mice
Q43880499Effects of sustained beta-adrenergic stimulation on ionic currents of cultured adult guinea pig cardiomyocytes
Q35575175Electrical Remodeling in Cardiac Hypertrophy
Q45969593Food restriction promotes downregulation of myocardial L-type Ca2+ channels.
Q48518785Gastric emptying and Ca(2+) and K(+) channels of circular smooth muscle cells in diet-induced obese prone and resistant rats
Q46764763Genomic and non-genomic regulation of L-type calcium channels in rat ventricle by thyroid hormone
Q36744608Identification of Glycosylation Sites Essential for Surface Expression of the CaVα2δ1 Subunit and Modulation of the Cardiac CaV1.2 Channel Activity
Q37219737Impact of calcium-channel blockers on right heart function in a controlled model of chronic pulmonary hypertension
Q44417703Impaired beta-adrenergic response and decreased L-type calcium current of hypertrophied left ventricular myocytes in postinfarction heart failure
Q37019326In vitro studies of early cardiac remodeling: impact on contraction and calcium handling
Q33278285Increased expression of the auxiliary beta(2)-subunit of ventricular L-type Ca(2)+ channels leads to single-channel activity characteristic of heart failure
Q42094321Increasing cardiac contractility after myocardial infarction exacerbates cardiac injury and pump dysfunction
Q35045042Inhibition of cyclic GMP hydrolysis with zaprinast reduces basal and cyclic AMP-elevated L-type calcium current in guinea-pig ventricular myocytes
Q38337468Involvement of L-type calcium channel and SERCA2a in myocardial dysfunction induced by obesity
Q26829681Ion Channels in the Heart
Q37308218L-type calcium channel C terminus autoregulates transcription
Q37170886L-type calcium channel current up-regulation by chronic stress is associated with increased alpha(1c) subunit expression in rat ventricular myocytes
Q26853101L-type calcium channel targeting and local signalling in cardiac myocytes
Q37493170Loss of β-adrenergic-stimulated phosphorylation of CaV1.2 channels on Ser1700 leads to heart failure
Q37431997Molecular basis for zinc transporter 1 action as an endogenous inhibitor of L-type calcium channels
Q26800076Myocardial hypertrophy and its role in heart failure with preserved ejection fraction
Q33825289Myocyte contractile dysfunction with hypertrophy and failure: relevance to cardiac surgery
Q43744292Myofilament Ca2+ desensitization mediates positive lusitropic effect of neuronal nitric oxide synthase in left ventricular myocytes from murine hypertensive heart.
Q30852031Myoscape controls cardiac calcium cycling and contractility via regulation of L-type calcium channel surface expression
Q44466123Negative modulation of L-type Ca2+ channels via beta-adrenoceptor stimulation in guinea-pig detrusor smooth muscle cells
Q42636139Negatively charged residues in the first extracellular loop of the L-type CaV1.2 channel anchor the interaction with the CaVα2δ1 auxiliary subunit
Q35146909Pathogenetic basis of myocardial dysfunction and amenability to reversal
Q38703819Proteolytic cleavage of the hydrophobic domain in the CaVα2δ1 subunit improves assembly and activity of cardiac CaV1.2 channels
Q36837883Pyruvate restores β-adrenergic sensitivity of L-type Ca(2+) channels in failing rat heart: role of protein phosphatase
Q40798269Regulation of L-type calcium channels in pituitary GH(4)C(1) cells by depolarization
Q36444526Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy
Q102053331Selective changes in cytosolic β-adrenergic cAMP signals and L-type Calcium Channel regulation by Phosphodiesterases during cardiac hypertrophy
Q35128926The long QT interval is not only inherited but is also linked to cardiac hypertrophy
Q33698658The structure and function of the cardiac myocyte: a review of fundamental concepts
Q80362737Time course of changes in the expression of DHPR, RyR(2), and SERCA2 after myocardial infarction in the rat left ventricle
Q37422609Transgenic simulation of human heart failure-like L-type Ca2+-channels: implications for fibrosis and heart rate in mice.
Q64058908YiQiFuMai Powder Injection Attenuates Coronary Artery Ligation-Induced Heart Failure Through Improving Mitochondrial Function via Regulating ROS Generation and CaMKII Signaling Pathways

Search more.